Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma
Clinical trial NCT02765243 · COMPLETED
Trial details
- NCT number
- NCT02765243
- Sponsor
- Zhujiang Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-01-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.